3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
8
Leukemia, Myeloid, Chronic-Phase
7
Burkitt Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Philadelphia Chromosome
2
Pancreatic Neoplasms
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Glioma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Interventions
Cyclophosphamide
8
Methotrexate
6
ponatinib
5
fludarabine phosphate
5
merphos
4
Whole-Body Irradiation
4
Tacrolimus
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cytarabine
3
CT-P10
3
Busulfan
3
letermovir
2
blinatumomab
2
Vincristine
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Melphalan
2
Cyclosporine
2
venetoclax
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
bosutinib
1
auricularum
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
Dasatinib
×
1 year
×
Clear all
No trials found.